A cluster analysis of epidemiological and clinical factors associated with the accumulation process of the burden of COVID-19 in European countries.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
10 11 2020
10 11 2020
Historique:
received:
25
06
2020
accepted:
03
08
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
17
3
2021
Statut:
epublish
Résumé
Background and aim of the work European COVID-19 statistics showed differentiation between mortality and new cases. Some studies suggested several factors including migration, cancer incidence, life expectancy and health system capacity maybe associated with differentiations. Up to now, impact of those factors in different European societies is not discussed and compared. Aim of the present study was to perform the cluster analysis in European countries in attention to clinical and epidemiological factors due to covid-19. Methods We collected some appropriate extreme data of COVID-19 to access the situations by ANOVA post-hoc test in 3 scenarios, as well as to estimate regression coefficients in simple linear regression, and a cluster analysis using average linkage. Covid-19 Statistics were considered in all analyses until April 24, 2020. Results Among 39 European countries, several countries reported highest rate of confirmed cases included of Italy (current statues=2270.52) and Spain (current status=2616.24). The highest rate of mortality was seen in France (current status=242.16), Italy (current status=305.52). Life expectancy (female) (P=0.01, 95%Cl=1521.27,15264.58), migration (P<0.001, 95%Cl=41.42,96.72) had significant association with confirmed cases and death. Overall cancer death (P<0.001, 95%Cl=0.36,0.68; P<0.001, 95%Cl=0.01,0.07) and lung cancer death (P<0.001, 95%Cl=1.97,3.56; P<0.001, 95%Cl=0.09,0.37) associated with confirmed cases and mortality, too. We were also determined 5 clusters which more than 30 countries were categorized in the first cluster. Conclusions Demographic factors, including population, life expectancy and migration, underlying disorders, such as several types of cancers, especially lung cancers lead to various distribution of COVID-19 in terms of prevalence and mortality, across European counties.
Identifiants
pubmed: 33682803
doi: 10.23750/abm.v92i1.10090
pmc: PMC7975970
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021022Références
Lancet Respir Med. 2020 Jun;8(6):542-544
pubmed: 32278368
Int J Environ Res Public Health. 2020 Mar 04;17(5):
pubmed: 32143519
J Clin Virol. 2020 May;126:104345
pubmed: 32278298
Public Health. 2020 Feb;179:A1-A2
pubmed: 32111295
Crit Rev Oncol Hematol. 2020 Jun;150:102972
pubmed: 32344317
Int J Antimicrob Agents. 2020 May;55(5):105955
pubmed: 32234468
ESMO Open. 2020 Apr;5(2):e000765
pubmed: 32245904
Anaesth Crit Care Pain Med. 2020 Apr;39(2):163-166
pubmed: 32088344
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Nat Rev Clin Oncol. 2020 May;17(5):268-270
pubmed: 32242095
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Thorac Cancer. 2020 Jun;11(6):1752-1757
pubmed: 32291968
BMJ. 2020 Mar 26;368:m1213
pubmed: 32217531
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3434-3436
pubmed: 32329810
BMJ. 2020 Apr 1;369:m1327
pubmed: 32238354